BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 3829973)

  • 1. Nephrotoxicity of cisplatin in rats.
    Nakada J; Machida T; Endou H
    Dev Toxicol Environ Sci; 1986; 14():179-82. PubMed ID: 3829973
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
    Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Morphologic observations on preventional effect of fosfomycin to nephrotoxicity induced by cisplatin].
    Ogawa T; Ryoke K; Hamada T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):84-91. PubMed ID: 3379336
    [No Abstract]   [Full Text] [Related]  

  • 4. Gluconeogenesis and ammonia production in the isolated perfused rat kidney: the effect of starvation, acidosis and diabetic ketosis.
    Goto E; Sakakibara F; Nishida T; Kawamura T; Sano T; Tsuchida I; Sakamoto N
    Nagoya J Med Sci; 1984 Mar; 46(1-4):67-78. PubMed ID: 6429544
    [No Abstract]   [Full Text] [Related]  

  • 5. Cisplatin-induced alterations in renal structure, ammoniagenesis and gluconeogenesis of rats.
    Nosaka K; Nakada J; Endou H
    Kidney Int; 1992 Jan; 41(1):73-9. PubMed ID: 1593864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis-diamminedichloroplatinum(II) nephrotoxicity and its relationship to renal gamma-glutamyl transpeptidase and glutathione.
    Leyland-Jones B; Morrow C; Tate S; Urmacher C; Gordon C; Young CW
    Cancer Res; 1983 Dec; 43(12 Pt 1):6072-6. PubMed ID: 6139163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats.
    González R; Borrego A; Zamora Z; Romay C; Hernández F; Menéndez S; Montero T; Rojas E
    Mediators Inflamm; 2004 Dec; 13(5-6):307-12. PubMed ID: 15770045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
    Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
    Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats.
    Tikoo K; Bhatt DK; Gaikwad AB; Sharma V; Kabra DG
    FEBS Lett; 2007 May; 581(10):2027-35. PubMed ID: 17470369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thymic factor, FTS, attenuates cisplatin nephrotoxicity by suppressing cisplatin-induced ERK activation.
    Kohda Y; Kawai Y; Iwamoto N; Matsunaga Y; Aiga H; Awaya A; Gemba M
    Biochem Pharmacol; 2005 Nov; 70(9):1408-16. PubMed ID: 16154539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin nephrotoxicity.
    Safirstein R; Wiston J
    J UOEH; 1987 Mar; 9 Suppl():216-22. PubMed ID: 3299604
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
    González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
    Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
    Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
    Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of glucose on renal gluconeogenesis.
    Dzúrik R; Cachovanová T
    Physiol Bohemoslov; 1969; 18(3):233-8. PubMed ID: 4245125
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisplatin-induced nephrotoxicity causes altered renal hemodynamics in Wistar Kyoto and spontaneously hypertensive rats: role of augmented renal alpha-adrenergic responsiveness.
    Hye Khan MA; Abdul Sattar M; Abdullah NA; Johns EJ
    Exp Toxicol Pathol; 2007 Nov; 59(3-4):253-60. PubMed ID: 17764917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats.
    Ali BH; Al-Moundhri M; Tageldin M; Al Husseini IS; Mansour MA; Nemmar A; Tanira MO
    Food Chem Toxicol; 2008 Nov; 46(11):3355-9. PubMed ID: 18790000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.